Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Iovance Biotherapeutics Stock a Buy Now?

TheMotleyFool

0 0

Is Iovance Biotherapeutics Stock a Buy Now?: https://g.foolcdn.com/editorial/images/772580/physician-shaking-patients-hand.jpg

Is this the start of a comeback for Iovance Biotherapeutics (NASDAQ: IOVA)? Though the small-cap biotech has significantly trailed the broader market in the past five years, its shares are up by 50% since 2024 started. Iovance is making progress on several fronts (more on that below).

It's no wonder that many investors are increasingly excited about the company's direction. But should long-term investors put their hard-earned money into this stock today? Let's find out.